Can Mounjaro Change Your Period?

Why does losing weight on Mounjaro affect your periods?

The connection between body weight and menstrual health is well established. Oestrogen is partly produced and stored in fat tissue, so when body fat falls quickly, circulating oestrogen levels can drop in a short window of time. The hypothalamic-pituitary-ovarian axis (the hormonal relay between the brain and the ovaries) is sensitive to energy availability, and a significant calorie deficit can temporarily suppress or disrupt the signals that regulate ovulation.

Mounjaro reduces appetite substantially. In the SURMOUNT-1 trial, participants lost on average around 20% of their body weight over 72 weeks, and much of that change happened in the first several months. That rate of change is fast enough to register hormonally. The result, for some women, is a cycle that skips, shortens, or becomes unpredictable during the earlier months of treatment.

This is broadly the same mechanism seen after bariatric surgery or with other GLP-1 medicines. It is not specific to tirzepatide. The NHS notes that weight loss itself can cause menstrual irregularity, and this general principle applies across weight-loss treatments that produce rapid results. For most women the cycle stabilises as weight and metabolism reach a new equilibrium, but the timeline is individual.

Can Mounjaro make periods heavier, or stop them altogether?

Both have been reported, and neither is guaranteed. Some women find that cycles previously disrupted by polycystic ovary syndrome (PCOS) or excess weight actually become more regular once insulin sensitivity and hormonal balance improve. For women with PCOS in particular, the metabolic effects of tirzepatide may restore ovulation in cycles that had been absent or unpredictable, which carries an important implication: fertility can increase even before a normal cycle is fully re-established.

Others experience the opposite: a heavier flow, more cramping, or periods that arrive further apart than usual. A minority of women describe periods stopping for a month or two. There is a dedicated page on whether Mounjaro can stop periods that covers the temporary-absence scenario in more detail, including when a missed period warrants a pregnancy test.

What matters clinically is the pattern over time. One unusual cycle shortly after starting or increasing a dose is generally lower concern than several consecutive abnormal cycles or a sudden, significant change in bleeding that has no other explanation. Either way, the right person to assess it is a GP or your prescriber, not a forum.

What about the contraceptive pill, is it still effective?

This is one of the most practically important questions, and the answer is specific to tirzepatide. Because Mounjaro slows gastric emptying, the absorption of oral contraceptives may be reduced, particularly in the first weeks of treatment and after each dose step-up. NHS guidance (echoed on the NHS England weight-management injections page) advises adding a non-oral method such as condoms for the first four weeks of treatment and for four weeks after every dose increase. That window covers the period when gastric motility is most affected.

There is no equivalent evidence of reduced pill effectiveness for semaglutide (Wegovy), so this is not a blanket GLP-1 rule, it applies to tirzepatide specifically. Women using patches, implants, or hormonal coils are not thought to be affected because those methods bypass the gut entirely. If you are considering changing to a different type of contraception or are uncertain about your current method's reliability, a conversation with a GP or sexual health service is worth having before or shortly after starting Mounjaro. You can also find broader context on taking Mounjaro during your period, including timing and practical considerations.

One further note: if your cycle becomes unpredictable during treatment, it can be easy to dismiss a late period as a medication effect. If there is any chance of pregnancy, test early rather than waiting. Mounjaro is not recommended during pregnancy.

When should a period change prompt a conversation with a clinician?

Minor irregularity in the first one to three months is common and, for most women, self-resolving. The situations that warrant a prompt conversation with a GP or your prescriber include: cycles consistently absent for three months or more, very heavy bleeding that soaks through protection unusually quickly, severe pain significantly beyond your normal range, or any changes that concern you independently of their cause.

If you are a patient with nume and something shifts in a way that worries you, our prescribers are available seven days a week, reaching the support team is straightforward. Menstrual changes are one of the questions our clinical team hears regularly in aftercare. You are not the first person to ask, and there is no threshold of severity required before you raise it.

Understanding how tirzepatide works in the body can also help contextualise these changes. The tirzepatide overview page explains the dual GIP and GLP-1 mechanism in plain terms. And if you are still weighing up whether treatment is right for you, the Mounjaro treatment page covers eligibility and how to take the next step. Treatment costs are worth understanding before you start too, transparent pricing with no subscription means no surprises later. If your injection day no longer suits your schedule, our guidance on whether you can change the day you take your Mounjaro explains how to do so safely.